Table 2.
Day 10 in situ efficacy results
| In situ efficacy results—treatment comparison of profilometry levels (μm) general linear mixed model evaluable participants (N = 34) | ||||
|---|---|---|---|---|
| Visit/treatment | Original scale in μm estimated median (SE)a | 95 % Confidence interval of the estimated mean | Natural log scale mean (SE) | % Reduction vs. SMFP/arginine (p value)b |
| 10 days post baseline (participant variance = 0.0264, residual variance = 0.7869) | ||||
| Stabilized SnF2 | 0.0747 (0.008) | (0.060, 0.093) | −2.5946 (0.1116) | 93.9 % (p < 0.0001) |
| SMFP/1.5 % arginine | 1.2255 (0.138) | (0.980, 1.532) | 0.2033 (0.1125) | |
aEstimated medians in micrometer were obtained by using the exponential function on the means from the natural logarithm scale (e mean)
bPercent reduction was calculated using back-transformed means as 100 % (SMFP/1.5 % arginine − Stabilized SnF2) / SMFP/1.5 % arginine. Two-sided p values for testing the mean difference between treatments were provided